Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients.

Du Pan SM, Scherer A, Gabay C, Finckh A.

Ann Rheum Dis. 2012 Jun;71(6):997-9. doi: 10.1136/annrheumdis-2011-200882. Epub 2012 Jan 30.

PMID:
22294628
[PubMed - indexed for MEDLINE]
2.

Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists.

Isaacs JD.

Expert Opin Biol Ther. 2009 Dec;9(12):1463-75. doi: 10.1517/14712590903379494. Review.

PMID:
19916731
[PubMed - indexed for MEDLINE]
3.

[New drugs and treatment strategies for rheumatoid arthritis].

Fantini F.

Recenti Prog Med. 2003 Sep;94(9):361-79. Review. Italian.

PMID:
12942798
[PubMed - indexed for MEDLINE]
4.

Strategies after the failure of the first anti-tumor necrosis factor alpha agent in rheumatoid arthritis.

Papagoras C, Voulgari PV, Drosos AA.

Autoimmun Rev. 2010 Jun;9(8):574-82. doi: 10.1016/j.autrev.2010.04.002. Epub 2010 Apr 28. Review.

PMID:
20433955
[PubMed - indexed for MEDLINE]
5.

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis.

Salliot C, Finckh A, Katchamart W, Lu Y, Sun Y, Bombardier C, Keystone E.

Ann Rheum Dis. 2011 Feb;70(2):266-71. doi: 10.1136/ard.2010.132134. Epub 2010 Nov 19. Review. Erratum in: Ann Rheum Dis. 2011 Mar;70(3):560.

PMID:
21097801
[PubMed - indexed for MEDLINE]
6.

[Management for TNF failure].

Mukai M.

Nihon Rinsho. 2007 Jul;65(7):1299-307. Review. Japanese.

PMID:
17642247
[PubMed - indexed for MEDLINE]
7.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

PMID:
17049139
[PubMed - indexed for MEDLINE]
Free Article
8.

Modulation of T-cell co-stimulation in rheumatoid arthritis: clinical experience with abatacept.

Laganà B, Vinciguerra M, D'Amelio R.

Clin Drug Investig. 2009;29(3):185-202. doi: 10.2165/00044011-200929030-00005. Review.

PMID:
19243211
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk